ALPHADROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Alphadrol, and when can generic versions of Alphadrol launch?
Alphadrol is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in ALPHADROL is fluprednisolone. There is one drug master file entry for this compound. Additional details are available on the fluprednisolone profile page.
Summary for ALPHADROL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 41 |
Patent Applications: | 3,664 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ALPHADROL at DailyMed |
US Patents and Regulatory Information for ALPHADROL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | ALPHADROL | fluprednisolone | TABLET;ORAL | 012259-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |